In life insurance, retirement savings and health, the turnover dropped by 3% to 35.7 billion EUR (37.8 billion USD). AXA attributed this result to the decline recorded in the healthcare sub-class of business following the non-renewal of two significant international contracts.
The Solvency II ratio stood at 230% as at 30 September, losing 5 points compared to 30 June 2023.
Read also | AXA, Tikehau and Unilever invest 126 million USD in Biobest [4]